Next Article in Journal
Autochthonous Human and Canine Strongyloides stercoralis Infection in Europe: Report of a Human Case in An Italian Teen and Systematic Review of the Literature
Next Article in Special Issue
Early-Onset HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis
Previous Article in Journal
Lassa Fever: Viral Replication, Disease Pathogenesis, and Host Immune Modulations
Previous Article in Special Issue
Antiretroviral Therapy in HTLV-1 Infection: An Updated Overview
Open AccessEditorial

Human T leukaemia Type 1 and COVID-19

1
The National Institute for Infectious Diseases, Fiocruz, Brazilian Ministry of Health and the Institute of Neurology, Federal University of Rio de Janeiro, Rio de Janeiro 21040-360, Brazil
2
Stonewall Medical Centre, Brisbane 4030, Australia
3
School of Public Health at University of Queensland, Brisbane 4006, Australia
*
Author to whom correspondence should be addressed.
Pathogens 2020, 9(6), 438; https://doi.org/10.3390/pathogens9060438
Received: 31 May 2020 / Accepted: 1 June 2020 / Published: 3 June 2020
(This article belongs to the Special Issue HTLV-1 Disease)
In the absence of clinical data on Human T leukaemia Type 1 and COVID-19 infection, we are providing guidance to clinicians who look after people living with HTLV-1. View Full-Text
MDPI and ACS Style

Araujo, A.; Martin, F. Human T leukaemia Type 1 and COVID-19. Pathogens 2020, 9, 438.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Search more from Scilit
 
Search
Back to TopTop